La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
GNS Panoramica delle azioni
Genus plc opera come società di genetica animale in Nord America, America Latina, Regno Unito, resto d'Europa, Medio Oriente, Russia, Africa e Asia.
| Punteggio fiocco di neve | |
|---|---|
| Valutazione | 2/6 |
| Crescita futura | 2/6 |
| Prestazioni passate | 2/6 |
| Salute finanziaria | 2/6 |
| Dividendi | 3/6 |
Premi
Analisi del rischio
Non sono stati rilevati rischi per GNS dai nostri controlli di rischio.
Genus plc Concorrenti
Storia dei prezzi e prestazioni
| Prezzi storici delle azioni | |
|---|---|
| Prezzo attuale dell'azione | UK£17.48 |
| Massimo di 52 settimane | UK£23.78 |
| Minimo di 52 settimane | UK£14.78 |
| Beta | 0.38 |
| 1Variazione di 1 mese | 5.94% |
| Variazione a 3 mesi | -6.62% |
| Variazione di 1 anno | -22.10% |
| 3Variazione a 3 anni | -70.65% |
| Variazione a 5 anni | -32.41% |
| Variazione dall'IPO | 1,194.81% |
Notizie e aggiornamenti recenti
The Price Is Right For Genus plc (LON:GNS)
Jun 16
Estimating The Fair Value Of Genus plc (LON:GNS)
Apr 20Is Genus (LON:GNS) Using Too Much Debt?
Mar 25With A 26% Price Drop For Genus plc (LON:GNS) You'll Still Get What You Pay For
Mar 05Recent updates
The Price Is Right For Genus plc (LON:GNS)
Jun 16Estimating The Fair Value Of Genus plc (LON:GNS)
Apr 20Is Genus (LON:GNS) Using Too Much Debt?
Mar 25With A 26% Price Drop For Genus plc (LON:GNS) You'll Still Get What You Pay For
Mar 05Genus (LON:GNS) Has Affirmed Its Dividend Of £0.103
Feb 25Getting In Cheap On Genus plc (LON:GNS) Might Be Difficult
Jan 17Does This Valuation Of Genus plc (LON:GNS) Imply Investors Are Overpaying?
Dec 10We Think Genus (LON:GNS) Is Taking Some Risk With Its Debt
Nov 03Calculating The Intrinsic Value Of Genus plc (LON:GNS)
Sep 09Is Genus (LON:GNS) A Risky Investment?
Mar 29Is Genus (LON:GNS) Using Too Much Debt?
Dec 21It's Unlikely That Shareholders Will Increase Genus plc's (LON:GNS) Compensation By Much This Year
Nov 17Genus (LON:GNS) Has Affirmed Its Dividend Of £0.217
Oct 25Genus (LON:GNS) Is Paying Out A Dividend Of £0.217
Oct 11Genus' (LON:GNS) Dividend Will Be £0.217
Sep 11A Look At The Fair Value Of Genus plc (LON:GNS)
Sep 09A Look At The Intrinsic Value Of Genus plc (LON:GNS)
May 31Is Genus (LON:GNS) A Risky Investment?
Mar 29Genus (LON:GNS) Has Re-Affirmed Its Dividend Of UK£0.10
Feb 27Is Genus plc (LON:GNS) Expensive For A Reason? A Look At Its Intrinsic Value
Jan 22With EPS Growth And More, Genus (LON:GNS) Is Interesting
Oct 29Here's Why Genus (LON:GNS) Can Manage Its Debt Responsibly
Oct 14Genus (LON:GNS) Could Easily Take On More Debt
Apr 05Is Genus' (LON:GNS) 235% Share Price Increase Well Justified?
Mar 18Trade Alert: The Independent Non-Executive Chairman Of Genus plc (LON:GNS), Iain G. Ferguson, Has Just Spent UK£73k Buying 150% More Shares
Feb 28I Ran A Stock Scan For Earnings Growth And Genus (LON:GNS) Passed With Ease
Feb 26How Much Of Genus plc (LON:GNS) Do Institutions Own?
Feb 01
Genus plc (LON:GNS) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?
Dec 22Have Genus plc (LON:GNS) Insiders Been Selling Their Stock?
Dec 05Is Genus' (LON:GNS) Share Price Gain Of 195% Well Earned?
Nov 20Rendimenti per gli azionisti
| GNS | GB Biotechs | GB Mercato | |
|---|---|---|---|
| 7D | -0.1% | 1.7% | 1.7% |
| 1Y | -22.1% | -17.3% | 13.1% |
Ritorno vs Industria: GNS underperformed the UK Biotechs industry which returned -17.8% over the past year.
Rendimento vs Mercato: GNS underperformed the UK Market which returned 12.5% over the past year.
Volatilità dei prezzi
| GNS volatility | |
|---|---|
| GNS Average Weekly Movement | 5.6% |
| Biotechs Industry Average Movement | 6.5% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 9.7% |
| 10% least volatile stocks in GB Market | 2.6% |
Prezzo delle azioni stabile: GNS has not had significant price volatility in the past 3 months.
Volatilità nel tempo: GNS's weekly volatility (6%) has been stable over the past year.
Informazioni sull'azienda
| Fondato | I dipendenti | AMMINISTRATORE DELEGATO | Sito web |
|---|---|---|---|
| 1994 | 3,500 | JK Kokke | www.genusplc.com |
Genus plc opera come società di genetica animale in Nord America, America Latina, Regno Unito, resto d'Europa, Medio Oriente, Russia, Africa e Asia. L'azienda opera attraverso tre segmenti: Genus PIC, Genus ABS e Genus Ricerca e Sviluppo. Con il marchio PIC, l'azienda vende suini da riproduzione e sperma per l'allevamento di suini con varie caratteristiche per la produzione di carne suina.
Genus plc Riepilogo dei fondamenti
| GNS statistiche fondamentali | |
|---|---|
| Capitalizzazione di mercato | UK£1.15b |
| Guadagni(TTM) | UK£33.40m |
| Ricavi(TTM) | UK£673.10m |
34.3x
Rapporto P/E1.7x
Rapporto P/SGNS è sopravvalutato?
Vedi Fair Value e analisi di valutazioneGuadagni e ricavi
| GNS Conto economico (TTM) | |
|---|---|
| Ricavi | UK£673.10m |
| Costo del fatturato | UK£429.10m |
| Profitto lordo | UK£244.00m |
| Altre spese | UK£210.60m |
| Guadagni | UK£33.40m |
Ultimi guadagni dichiarati
Dec 31, 2023
Prossima data di guadagno
Sep 05, 2024
| Utile per azione (EPS) | 0.51 |
| Margine lordo | 36.25% |
| Margine di profitto netto | 4.96% |
| Rapporto debito/patrimonio netto | 40.7% |
Come si è comportato GNS nel lungo periodo?
Vedi performance storica e confronto